Navigation Links
Private Equity and Venture Capital (PE/VC) Activity in Medical Devices - Number of Investments in Smaller Companies has Increased over the Past Four Years
Date:1/3/2012

>5.18.2 Investor Acquired 34% Stake in Molnlycke Health Care 82

5.18.3 Nordic Capital Fund and Avista Capital Partners Acquire ConvaTec from Bristol-Myers Squibb 83

5.18.4 Investor and Morgan Stanley Completed Acquisition of Molnlycke Health Care from Apax Partners 84

6 Global Medical Devices, Top Financial Advisors 86

6.1 Top Financial Advisors, PE/VC Deals Medical Devices 86

7 PE/VC Activity in Medical Devices- Appendix 87

7.1 Acronyms 87

7.2 Research Methodology 88

7.2.1 Secondary Research 88

7.2.2 Primary Research 88

7.2.3 Models 89

7.2.4 Forecasts 89

7.2.5 Expert Panels 89

7.3 Contact Us 89

7.4 Disclaimer 90

7.5 Sources 90

List of Tables

1.1 List of Tables

Table 1: Medical Devices Market, Global, PE/VC, by Number of Deals and Deal Value, 2007-2010 10

Table 2: Medical Devices Industry, Global, PE/VC Deals, Number of Deals by Stages, 2007-2010 11

Table 3: Medical Devices Industry, Global, PE/VC Deals, Withdrawn/Terminated Deals, 2007–2010 12

Table 4: Medical Devices Industry, North America, PE/VC Deals, by Deal Volume and Deal Value ($m), 2007–2010 17

Table 5: Medical Devices, Europe, PE/VC Deals, by Deal Volume and Deal Value ($m), 2007–2010 19

Table 6: Medical Devices Industry, Asia-Pacific, PE/VC Deals, by Deal Volume and Deal Value ($m), 2007–2010 21

Table 7: In Vitro Diagnostics Market, Global, PE/VC, by Number of Deals, 2007–2010 23

Table 8: In Vitro Diagnostics Market, Global, PE/VC, by Deal Value ($m), 2007–2010 23

Table 9: In Vitro Diagnostics, Global, PE/VC Deals, 2007–2010 24

Table 10: Cardiovascular Devices Market, Global, PE/VCs, by Number of Deals, 2007–2010 29

Table 11: Cardiovascular Devices Market, Global, PE/VCs, by Deal Value ($m), 2007–2010 29

Table 12: Cardiovascular Devices, Global,
'/>"/>

SOURCE Reportlinker
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11

Related medicine technology :

1. Paratek Pharmaceuticals Announces the Close of $40 Million Private Placement to Finance Programs to Combat MRSA Infections
2. NeuroVasx, Inc. Announces $8.5 Million Private Placement and Completion of cPAX Aneurysm Treatment Study
3. Lixte Biotechnology Holdings, Inc. Announces Completion of Private Placement
4. Radius Raises Additional $15 Million, Increasing Second Private Equity Financing Round to $82.5 Million
5. Ikaria(R) Named Private Company of the Year by New Jersey Technology Council
6. Pharmacyclics, Inc. Announces Closing of a Private Financing With the Principals of Pacific Biopharma Group, Ltd.
7. CTMM Becomes One of the Worlds Largest Public-Private Partnerships in Translational Medical Research
8. invivodata Recognized as One of Pittsburghs Fastest Growing Private Companies
9. DOR BioPharma Announces Private Equity Financing of $3.85 Million with its Partner Sigma-Tau and Other Institutional Investors
10. Private Investment Firm Czura Thornton Today Introduces Clearstone Central Laboratories as the Newest Member of the Czura Thornton Life Science Group
11. World Heart Corp. Completes $7.3 Million Private Placement
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/30/2015)... 30, 2015  EP Global Communications, Inc. (Public OTC: ... contacted the Company about discussing EPGL,s electronic contact ... Monday, August 3, 2015.  Novartis CEO Joe ... the coming electronic contact lens market could be ... next several years.  Novartis partnered with Google in ...
(Date:7/30/2015)... OAKS, Calif., July 30, 2015  Amgen (NASDAQ: ... the second quarter of 2015. Key results include: ... the second quarter of 2014 to $5,370 million, ... by Enbrel ® (etanercept), Prolia ® ... (carfilzomib) and XGEVA ® (denosumab). Unfavorable changes ...
(Date:7/30/2015)... July 30, 2015  Cleveland Clinic President Wael ... address last month that industry is compelled to adopt ... gain the efficiencies—and develop the transformational innovations -- required ... comments were preceded by Doug Kohrs , past ... moderator, who stressed that industry must add "episode of ...
Breaking Medicine Technology:Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 2Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 3Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 4Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 5Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 6Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 7Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 8Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 9Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 10Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 11Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 12Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 13Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 14Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 15Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 16Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 17Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 18Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 19Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 20Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 21Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 22Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 23Orthopaedic Surgery Reimbursement Shifts to Episode of Care 2
... SAN CARLOS, Calif., June 23, 2011 PharmacoFore, ... abuse-resistant prescription drugs, today announced positive results from ... its hydromorphone (HM) Bio-Activated Molecular Delivery™ (Bio-MD™) product ... will present at the 2011 BIO Business Forum ...
... Today,s U.S. Supreme Court decision in ... safety, giving generic drug companies legal immunity when they ignore ...  This decision eliminates any incentive for generic manufacturers to ensure ... drugs, potential dangers. This decision also means that ...
Cached Medicine Technology:PharmacoFore, Inc. Announces Positive Results from a Phase I Clinical Study of Its Hydromorphone Bio-Activated Molecular Delivery™ System, and Upcoming Presentation at the 2011 BIO Business Forum During the Annual BIO International Convention in Was 2PharmacoFore, Inc. Announces Positive Results from a Phase I Clinical Study of Its Hydromorphone Bio-Activated Molecular Delivery™ System, and Upcoming Presentation at the 2011 BIO Business Forum During the Annual BIO International Convention in Was 3PharmacoFore, Inc. Announces Positive Results from a Phase I Clinical Study of Its Hydromorphone Bio-Activated Molecular Delivery™ System, and Upcoming Presentation at the 2011 BIO Business Forum During the Annual BIO International Convention in Was 4Generic Drug Decision Disastrous to Patient Safety 2
(Date:7/31/2015)... ... July 31, 2015 , ... As part of their company mission, ... of animal welfare organizations is essential to the longevity of their business. It ... National Association of Professional Pet Sitters (NAPPS) annual Presents 4 Pets supply drive. ...
(Date:7/31/2015)... , ... July 31, 2015 , ... ... “HARMONY 2015”, one of the industry’s premier thought leadership symposiums, hosted by ... and 6. The event attracts over 250 “C”-level executives, administrators, directors of ...
(Date:7/31/2015)... IL (PRWEB) , ... July 31, 2015 , ... The ... Boston, when Major League Baseball and the Boston Red Sox honor Ice Bucket co-founders ... the challenge. MLB is donating $100,000 to further collaborative efforts among the ALS organizations ...
(Date:7/31/2015)... ... July 31, 2015 , ... Successful Import/Export ... http://www.fdanews.com/importexportprogram , Having FDA-regulated products held at ports costs time, money ... risking containment — or even destruction — of products, an FDA insider shows ...
(Date:7/31/2015)... ... July 31, 2015 , ... ... a blog post that encourages the understanding and treatment of ankle sprains. A ... for in-home remedies. This can be dangerous if the condition augments and causes ...
Breaking Medicine News(10 mins):Health News:Dallas-based Park Cities Pet Sitter Selects Non-Profit Animal Welfare Organization “Angie’s Friends” as this Year’s Recipient of their Presents 4 Pets Supply Drive. 2Health News:Dallas-based Park Cities Pet Sitter Selects Non-Profit Animal Welfare Organization “Angie’s Friends” as this Year’s Recipient of their Presents 4 Pets Supply Drive. 3Health News:Dallas-based Park Cities Pet Sitter Selects Non-Profit Animal Welfare Organization “Angie’s Friends” as this Year’s Recipient of their Presents 4 Pets Supply Drive. 4Health News:Harmony Healthcare International Announces Speaker Line-up for “HARMONY 2015” 2Health News:Harmony Healthcare International Announces Speaker Line-up for “HARMONY 2015” 3Health News:Major League Baseball Joins MDA and Fourteen Other ALS Organizations to Launch ALS Ice Bucket Challenge 2015 2Health News:Major League Baseball Joins MDA and Fourteen Other ALS Organizations to Launch ALS Ice Bucket Challenge 2015 3Health News:Major League Baseball Joins MDA and Fourteen Other ALS Organizations to Launch ALS Ice Bucket Challenge 2015 4Health News:FDAnews Announces — Successful Import/Export Programs: Former FDA Expert Shows the Way, Oct. 20-21, 2015 2Health News:FDAnews Announces — Successful Import/Export Programs: Former FDA Expert Shows the Way, Oct. 20-21, 2015 3Health News:FDAnews Announces — Successful Import/Export Programs: Former FDA Expert Shows the Way, Oct. 20-21, 2015 4Health News:Absolute PhysioCare & Sports Rehab Promotes Understanding & Treatment of Ankle Sprains 2
... SPRING HARBOR, N.Y. - In a variety ... stem cells have the potential to differentiate into a ... to a complete new organism. Stem cell research, ... biologists--reproductive biologists, cancer biologists, cell and developmental biologists, and ...
... Dermatologists emphasize treatment should be tailored to meet ... Ill., June 4 Based on an extensive review ... recognized psoriasis experts, the American Academy of Dermatology (Academy) ... and treatment of psoriasis with traditional systemic therapies. Recommendations, ...
... 4 Custom Spine announced today that Randal Clarke is ... Randy has been in the orthopedic medical device market ... for new products and building successful start-up organizations. ... representative for Zimmer, which was followed by a sales career ...
... PAUL, Minn., June 4 The Minneapolis-St. Paul office ... Marrow Donor Program to head the organization,s largest annual ... runs June 8-22, will work to reach a diverse ... advocates. For thousands of people with leukemia and other ...
... Pharmacy Management Technology, Will Offer Patients Any-Store Refills , ... LLC has selected PDX and affiliates Rx.com and NHIN as ... , , Albertson,s, LLC is replacing its current ... (EPS), unparalleled in efficiency, safety, and tools for ...
... before the current economic downturn, an American family filed for ... of them were insured. Over 60% of all bankruptcies in ... In an article published in the August 2009 issue of ... the first-ever national random-sample survey of bankruptcy filers shows that ...
Cached Medicine News:Health News:New interdisciplinary volume focuses on advances in stem cell research 2Health News:American Academy of Dermatology Issues New Guidelines For the Management of Psoriasis With Systemic Medications 2Health News:American Academy of Dermatology Issues New Guidelines For the Management of Psoriasis With Systemic Medications 3Health News:American Academy of Dermatology Issues New Guidelines For the Management of Psoriasis With Systemic Medications 4Health News:American Academy of Dermatology Issues New Guidelines For the Management of Psoriasis With Systemic Medications 5Health News:American Academy of Dermatology Issues New Guidelines For the Management of Psoriasis With Systemic Medications 6Health News:Custom Spine Welcomes Randal Clarke as Vice President of Sales 2Health News:Weber Shandwick Chosen By National Marrow Donor Program(R) To Head Awareness Campaign 2Health News:Weber Shandwick Chosen By National Marrow Donor Program(R) To Head Awareness Campaign 3Health News:Albertson's, LLC Selects PDX-NHIN-Rx.com to Provide Complete Pharmacy Management Solution 2Health News:Over 60 percent of all US bankruptcies attributable to medical problems 2
Used for common bile duct exploration. Supplied sterile in peel-open packages. Intended for one-time use....
... with the MAMMOTOME® HH (Hand ... invasive procedure using ultrasound imaging ... images to locate breast abnormalities, ... and map the area you ...
... Provides reliable strength for temporary wound ... which compliant and stretchable support material ... transudate is not required. Predictable absorption. ... be inert, nonantigenic, and nonpyrogenic. ,VICRYL ...
... Mesh plugs perform best when the ... contact with a smooth wall of highly ... means less tissue remodeling to help stabilize ... fills more of the defect with gentle ...
Medicine Products: